EANS-Adhoc: CHRIST WATER TECHNOLOGY AG / CHRIST reports preliminary figures as per 30.09.2009 prior to the expiry of the Acceptance Period of the GLV takeover offer

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Company Information

16.11.2009

With respect to the expiry date Nov 17th, 2009 (4:00 pm) of the voluntary public
takeover offer bid of GLV Inc (via Eimco Water Technology GmbH) to the
shareholders of Christ Water Technology AG, the executive board of CHRIST
decided to report preliminary key figures for the quarter ended Sept 30th, 2009
(Q1 - Q3 results).

"The third quarter was dominated by the ongoing reshaping of CHRIST in a still
challenging economic environment and ended with the Closing of the sale of the
Pharma & Life Science business as per Sept 30th, 2009. The proceeds of this
transaction were a vital contribution to re-arrange and finance the streamlining
and focusing of CHRIST to the future core businesses in Ultrapure Water, Process
Water & Reuse and Municipal Water Treatment / Desalination (the continuing
operations)", says Malek Salamor, CEO of CHRIST

Besides the Food & Beverage activities, where CHRIST further evaluates the
possibility of entering into a strategic alliance, also the Pharma & Life
Science business will be reported in Q3 as discontinued operations.

Preliminary Key Figures Q1-Q3 2009 (YTD compared to prior period):

• Net Sales EUR 107 million (-23% continuing operat.) EUR 171 million
(-24%, contin.+discont.) • Order intake EUR 150 million (+56%;
continuing operat.) EUR 203 million (+8%; contin.+discont.) • Orders
on hand EUR 147 million (+13%; continuing operat.) EUR 160 million
(-14%; contin.+discont.) • EBIT EUR -2.1 million (EUR -4.5 million);
continuing operations • Net Result EUR -1.2 million (EUR -14 million
as per 30.09.08); continuing.+discontinued operation including the
special effect from sale of pharma business

• Equity EUR 35.8 million as per 30.09.09 (EUR 37 million as per 31.12.08)
• Net Debt EUR 45 million as per 30.09.09 (EUR 55 million as per 31.12.08) EUR
30 million as per 02.10.09 after receipt remaining cash of pharma transaction

Preliminary Key Figures Q3 2009 (compared to Q3 2008)

• EBIT EUR -3.0 million (EUR -4,5 million); continuing operations

• Net Result EUR -3.8 million (EUR -6.2 million); continuing
operations; EUR 3.4 million (EUR -15.5 million);
continuing.+discontinued operations including the special effect from
sale of pharma business

Operating result in continuing operations was hit by weak markets in
the industrial sector, including the microelectronics and general
industries where some expected order intakes have been further
delayed, thus resulting in an under-utilisation in CHRIST Ultrapure
and Process Water entities. Good market conditions and healthy
business activities can be reported from Municipal Water Treatment
Division. The cleaning and phasing out of loss-making projects in
power as well as in MWT also contributed to the negative result in
Q3.

The realised profit out of the sale of Pharma & Life Science business
was negatively impacted by a slowdown in several pharma markets in Q3
and the cost of settlement of P&LS activities and projects in the
course of the selling process.

Outlook

Malek Salamor: "It is a disappointing quarterly result for us,
especially if we look back on the positive restructuring jobs we have
done so far. But weak market conditions in important areas resulted
in further delays of project awards with immediate loss implication
in some key companies. Although the timing for placement of orders
always leaves room for uncertainty, we are confident to receive new
important double-digit million orders in the continuing business in
Q4 2009. The solid backlog at end of 2009 will be a strong base for
recovery and return to profitability."

In the light of still volatile markets, lagging impacts of
restructuring steps and the requirement of a sound financial basis
the executive board of CHRIST still supports the takeover offer of
GLV Group which would combine two technologically and regionally
mostly complementary groups of companies into a globally leading
water technology provider.

The full Quarterly Report will be published on November 27th, 2009.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: CHRIST WATER TECHNOLOGY AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Christ Water Technology AG

Mag. Ralf Burchert

ralf.burchert@christwater.com

Tel.: 06232/5011-1113

Branche: Biotechnology
ISIN: AT0000499157
WKN: 675399
Index: WBI, ATX Prime
Börsen: Wien / official market